Skip to content
Subcommittee Hearing

BioShield II: Responding to An Ever Changing Threat

Type: Subcommittee Hearing
Date:
Time: 10:00am
Location: Hart Senate Office Building Room 216
Status: SCHEDULED

Member Statements

Panel I

  • Christine Grant

    Vice President, Government Relations, Aventis
  • Alan P. Timmins

    Chief Executive Officer, AVI BioPharma
  • Carlos Angulo

    Partner, Zuckerman Spaeder, LLP
    Representing the Coalition for a Competitive Pharmaceutical Market
  • John Bartlett, M.D.

    Chief, Division of Infectious Diseases, Johns Hopkins University School of Medicine
    Representing the Infectious Disease Society of America (IDSA)
  • Kathleen Jaeger

    President and CEO
    Generic Pharmaceutical Association (GPhA)

Panel II